{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:26:37Z","timestamp":1791851197278,"version":"4.3.4"},"reference-count":156,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"VIT SEED GRANT"},{"name":"ICMR-National Task Force Project","award":["5\/7\/482\/2010-RBMH&CH"],"award-info":[{"award-number":["5\/7\/482\/2010-RBMH&CH"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.lfs.2020.117839","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T11:12:56Z","timestamp":1590145976000},"page":"117839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":184,"special_numbering":"C","title":["Coronaviruses pathogenesis, comorbidities and multi-organ damage \u2013 A review"],"prefix":"10.1016","volume":"255","author":[{"given":"Kaviyarasi","family":"Renu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pureti Lakshmi","family":"Prasanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abilash","family":"Valsala Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.117839_bb0005","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S0140-6736(20)30418-9","article-title":"Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19","volume":"395","author":"Calisher","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117839_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2020.117839_bb0015","series-title":"Features, Evaluation and Treatment Coronavirus (COVID-19), StatPearls","author":"Cascella","year":"2020"},{"key":"10.1016\/j.lfs.2020.117839_bb0020","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117839_bb0025","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.lfs.2020.117839_bb0030","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.lfs.2020.117839_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.138277","article-title":"COVID-19: a promising cure for the global panic","volume":"725","author":"Vellingiri","year":"2020","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.lfs.2020.117839_bb0040","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1016\/S0140-6736(20)30558-4","article-title":"Comorbidities and multi-organ injuries in the treatment of COVID-19","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.lfs.2020.117839_bb0045","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117839_bb0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0060","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.lfs.2020.117839_bb0065","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cardiores.2006.09.006","article-title":"ACE2 of the heart: from angiotensin I to angiotensin (1\u20137)","volume":"73","author":"Keidar","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2020.117839_bb0070","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.117839_bb0075","first-page":"1","article-title":"Review of the clinical characteristics of coronavirus disease 2019 (COVID-19)","author":"Jiang","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0080","series-title":"Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy","author":"Golan","year":"2011"},{"key":"10.1016\/j.lfs.2020.117839_bb0085","first-page":"S19","article-title":"Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders","volume":"9","author":"Fyhrquist","year":"1995","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.lfs.2020.117839_bb0090","series-title":"Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), and Direct Renin Inhibitors for Treating Essential Hypertension: An Update","author":"Sanders","year":"2011"},{"key":"10.1016\/j.lfs.2020.117839_bb0095","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1086\/313937","article-title":"Spectrum of clinical illness in hospitalized patients with \u201ccommon cold\u201d virus infections","volume":"31","author":"El-Sahly","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117839_bb0100","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.lfs.2020.117839_bb0105","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1086\/339881","article-title":"Rhinovirus and coronavirus infection-associated hospitalizations among older adults","volume":"185","author":"Falsey","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117839_bb0110","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117839_bb0115","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1126\/science.341.6147.702","article-title":"Researchers scramble to understand camel connection to MERS","volume":"341","author":"Kupferschmidt","year":"2013","journal-title":"American Association for the Advancement of Science."},{"key":"10.1016\/j.lfs.2020.117839_bb0120","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0125","author":"Tesini"},{"key":"10.1016\/j.lfs.2020.117839_bb0130","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/v7030996","article-title":"Identification of new respiratory viruses in the new millennium","volume":"7","author":"Berry","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.lfs.2020.117839_bb0135","author":"M. Clinic"},{"key":"10.1016\/j.lfs.2020.117839_bb0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, function, and evolution of coronavirus spike proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annual Review of Virology"},{"key":"10.1016\/j.lfs.2020.117839_bb0145","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.117839_bb0150","first-page":"1136","article-title":"Pathol ogy and pathogenesis of Severe Acute Respiratory Syndrome","volume":"170","author":"Gu","year":"2007","journal-title":"The American Journal of Patology"},{"key":"10.1016\/j.lfs.2020.117839_bb0155","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5858\/2004-128-195-AODDTS","article-title":"Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis","volume":"128","author":"Chong","year":"2004","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0160","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","article-title":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117839_bb0165","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/01.CIR.0000094737.21775.32","article-title":"Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study","volume":"108","author":"Li","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2020.117839_bb0170","first-page":"14","article-title":"Clinical feature in patients of sever acute respiratory syndrome with type 2 diabetes and secondary hyperglycemia","volume":"20","author":"Liao","year":"2004","journal-title":"Chinese Journal of Endocrinology and Metabolism"},{"key":"10.1016\/j.lfs.2020.117839_bb0175","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0180","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1523-1755.2005.67130.x","article-title":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome","volume":"67","author":"Chu","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2020.117839_bb0185","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/liv.14435","article-title":"Liver injury during highly pathogenic human coronavirus infections","volume":"40","author":"Xu","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.lfs.2020.117839_bb0190","first-page":"121","article-title":"Clinical characteristics and mechanism of liver function injury in 250 patients with severe acute respiratory syndrome","volume":"14","author":"LU","year":"2004","journal-title":"China Journal of Modern Medicine"},{"key":"10.1016\/j.lfs.2020.117839_bb0195","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3201\/eid1005.030640","article-title":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients","volume":"10","author":"Wang","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117839_bb0200","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/hep.20111","article-title":"SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases","volume":"39","author":"Chau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2020.117839_bb0205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4269\/ajtmh.2004.71.125","article-title":"Sequential changes of serum aminotransferase levels in patients with severe acute respiratory syndrome","volume":"71","author":"Wu","year":"2004","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"10.1016\/j.lfs.2020.117839_bb0210","first-page":"493","article-title":"Clinical characteristics and mechanism of liver injury in patients with severe acute respiratory syndrome","volume":"11","author":"Duan","year":"2003","journal-title":"Zhonghua gan zang bing za zhi= Zhonghua ganzangbing zazhi= Chinese journal of hepatology"},{"key":"10.1016\/j.lfs.2020.117839_bb0215","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/path.1560","article-title":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways","volume":"203","author":"Ding","year":"2004","journal-title":"The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland"},{"key":"10.1016\/j.lfs.2020.117839_bb0220","doi-asserted-by":"crossref","first-page":"14043","DOI":"10.1128\/JVI.78.24.14043-14047.2004","article-title":"Overexpression of 7a, a protein specifically encoded by the severe acute respiratory syndrome coronavirus, induces apoptosis via a caspase-dependent pathway","volume":"78","author":"Tan","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2020.117839_bb0225","first-page":"10","article-title":"Study of the relationship SARS and hepatitis virus B","author":"HUANG","year":"2003","journal-title":"Chinese Journal of Clinical Hepatology"},{"key":"10.1016\/j.lfs.2020.117839_bb0230","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/jcp.2003.013276","article-title":"Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS)","volume":"57","author":"Tse","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.lfs.2020.117839_bb0235","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/path.1440","article-title":"The clinical pathology of severe acute respiratory syndrome (SARS): a report from China","volume":"200","author":"Ding","year":"2003","journal-title":"The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland"},{"key":"10.1016\/j.lfs.2020.117839_bb0240","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(03)13413-7","article-title":"Lung pathology of fatal severe acute respiratory syndrome","volume":"361","author":"Nicholls","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117839_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/modpathol.3800247","article-title":"Pulmonary pathology of severe acute respiratory syndrome in Toronto","volume":"18","author":"Hwang","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lfs.2020.117839_bb0250","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0046-8177(03)00367-8","article-title":"Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore","volume":"34","author":"Franks","year":"2003","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.lfs.2020.117839_bb0255","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/00313020310001619118","article-title":"A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)","volume":"35","author":"Lang","year":"2003","journal-title":"Pathology"},{"key":"10.1016\/j.lfs.2020.117839_bb0260","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1056\/NEJMoa030685","article-title":"A major outbreak of severe acute respiratory syndrome in Hong Kong","volume":"348","author":"Lee","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0265","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.virusres.2007.01.022","article-title":"Pathogenetic mechanisms of severe acute respiratory syndrome","volume":"133","author":"Guo","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.lfs.2020.117839_bb0270","article-title":"New study shows SARS can infect brain tissue","author":"America","year":"2005","journal-title":"ScienceDaily"},{"key":"10.1016\/j.lfs.2020.117839_bb0275","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1128\/JVI.79.12.7819-7826.2005","article-title":"Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis","volume":"79","author":"Cheung","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2020.117839_bb0280","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2004-10-4166","article-title":"Chemokine up-regulation in sars-coronavirus\u2013infected, monocyte-derived human dendritic cells","volume":"106","author":"Law","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2020.117839_bb0285","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/JVI.80.6.2684-2693.2006","article-title":"Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro","volume":"80","author":"Yen","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2020.117839_bb0290","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00638-15","article-title":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection","volume":"6","author":"Totura","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.lfs.2020.117839_bb0295","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12985-016-0544-0","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) origin and animal reservoir","volume":"13","author":"Mohd","year":"2016","journal-title":"Virol. J."},{"key":"10.1016\/j.lfs.2020.117839_bb0300","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(15)60454-8","article-title":"Middle East respiratory syndrome","volume":"386","author":"Zumla","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117839_bb0305","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s12985-015-0439-5","article-title":"MERS coronavirus: diagnostics, epidemiology and transmission","volume":"12","author":"Mackay","year":"2015","journal-title":"Virol. J."},{"key":"10.1016\/j.lfs.2020.117839_bb0310","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00473-12","article-title":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans","volume":"3","author":"van Boheemen","year":"2012","journal-title":"MBio"},{"key":"10.1016\/j.lfs.2020.117839_bb0315","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1186\/s12889-018-5484-8","article-title":"MERS transmission and risk factors: a systematic review","volume":"18","author":"Park","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.lfs.2020.117839_bb0320","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1186\/s12889-016-3881-4","article-title":"Clinical determinants of the severity of Middle East respiratory syndrome (MERS): a systematic review and meta-analysis","volume":"16","author":"Matsuyama","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.lfs.2020.117839_bb0325","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijid.2016.06.015","article-title":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis","volume":"49","author":"Badawi","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117839_bb0330","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s15010-015-0720-y","article-title":"Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)","volume":"43","author":"Arabi","year":"2015","journal-title":"Infection"},{"key":"10.1016\/j.lfs.2020.117839_bb0335","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117839_bb0340","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/0885066615579858","article-title":"Characteristics and outcomes of Middle East respiratory syndrome coronavirus patients admitted to an intensive care unit in Jeddah, Saudi Arabia","volume":"31","author":"Al-Hameed","year":"2016","journal-title":"J. Intensive Care Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0345","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijid.2014.09.003","article-title":"Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia","volume":"29","author":"Saad","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117839_bb0350","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2020.117839_bb0355","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1078\/0171-9335-00302","article-title":"The multifunctional or moonlighting protein CD26\/DPPIV","volume":"82","author":"Boonacker","year":"2003","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.lfs.2020.117839_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145561","article-title":"Multi-organ damage in human dipeptidyl peptidase 4 transgenic mice infected with Middle East respiratory syndrome-coronavirus","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2020.117839_bb0365","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/his.13379","article-title":"Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection\u2013clinicopathological and ultrastructural study","volume":"72","author":"Alsaad","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.lfs.2020.117839_bb0370","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ajpath.2015.10.024","article-title":"Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014","volume":"186","author":"Ng","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.lfs.2020.117839_bb0375","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","article-title":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","volume":"104","author":"Mahallawi","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.lfs.2020.117839_bb0380","series-title":"WHO Report, Middle East Respiratory Syndrome Coronavirus (MERS-CoV)","year":"2019"},{"key":"10.1016\/j.lfs.2020.117839_bb0385","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3988\/jcn.2017.13.3.227","article-title":"Neurological complications during treatment of Middle East respiratory syndrome","volume":"13","author":"Kim","year":"2017","journal-title":"Journal of Clinical Neurology"},{"key":"10.1016\/j.lfs.2020.117839_bb0390","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhin.2016.10.008","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications","volume":"95","author":"Kim","year":"2017","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.lfs.2020.117839_bb0395","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MCP.0000000000000046","article-title":"Severe acute respiratory syndrome vs. the Middle East respiratory syndrome","volume":"20","author":"Hui","year":"2014","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0400","first-page":"10229","article-title":"Middle East respiratory syndrome","volume":"95","author":"Memish","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117839_bb0405","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1099\/vir.0.055533-0","article-title":"Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment","volume":"94","author":"Lau","year":"2013","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.lfs.2020.117839_bb0410","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1099\/jgv.0.000351","article-title":"Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells","volume":"97","author":"Tynell","year":"2016","journal-title":"The Journal of General Virology"},{"key":"10.1016\/j.lfs.2020.117839_bb0415","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/infdis\/jit504","article-title":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis","volume":"209","author":"Zhou","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117839_bb0420","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3346\/jkms.2016.31.11.1717","article-title":"Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection","volume":"31","author":"Kim","year":"2016","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.lfs.2020.117839_bb0425","first-page":"1","article-title":"COVID-19 and the cardiovascular system","author":"Zheng","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.lfs.2020.117839_bb0430","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","volume":"116","author":"Chen","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2020.117839_bb0435","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.RES.0000187500.24964.7A","article-title":"Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients","volume":"97","author":"Keidar","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.lfs.2020.117839_bb0440","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2020.117839_bb0445","first-page":"1","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0450","first-page":"891","article-title":"Aliskiren inhibits angiotensin II\/angiotensin 1-7 (Ang II\/Ang1-7) signal pathway in rats with diabetic nephropathy","volume":"34","author":"Ding","year":"2018","journal-title":"Xi bao yu fen zi mian yi xue za zhi= Chinese journal of cellular and molecular immunology"},{"key":"10.1016\/j.lfs.2020.117839_bb0455","doi-asserted-by":"crossref","first-page":"313-313","DOI":"10.1038\/s41569-020-0368-x","article-title":"Interaction between RAAS inhibitors and ACE2 in the context of COVID-19","volume":"17","author":"Mourad","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.lfs.2020.117839_bb0460","article-title":"A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias","author":"Zhao","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117839_bb0465","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0470","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMc2005073","article-title":"SARS-CoV-2 infection in children","volume":"382","author":"Lu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0475","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0480","doi-asserted-by":"crossref","unstructured":"F. Xiao, M. Tang, X. Zheng, C. Li, J. He, Z. Hong, S. Huang, Z. Zhang, X. Lin, Z. Fang, Evidence for gastrointestinal infection of SARS-CoV-2, medRxiv, (2020).","DOI":"10.1101\/2020.02.17.20023721"},{"key":"10.1016\/j.lfs.2020.117839_bb0485","first-page":"1","article-title":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding","author":"Xu","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0490","series-title":"Novel Coronavirus Could be Targeting Kidneys, Suggests New Data","author":"H.I.S. Writers","year":"2020"},{"key":"10.1016\/j.lfs.2020.117839_bb0495","first-page":"1","article-title":"Coronavirus disease 19 infection does not result in acute kidney injury: an analysis of 116 hospitalized patients from Wuhan, China","author":"Wang","year":"2020","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.lfs.2020.117839_bb0500","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2020.117839_bb0505","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117839_bb0510","series-title":"Clinical Features of COVID-19-Related Liver Damage","author":"Fan","year":"2020"},{"key":"10.1016\/j.lfs.2020.117839_bb0515","series-title":"Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage after 2019-nCoV Infection, bioRxiv","author":"Chai","year":"2020"},{"key":"10.1016\/j.lfs.2020.117839_bb0520","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology","volume":"16","author":"Banales","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2020.117839_bb0525","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0530","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jtho.2020.02.010","article-title":"Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer","volume":"15","author":"Tian","year":"2020","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lfs.2020.117839_bb0535","article-title":"Some patients who survive COVID-19 may suffer lasting lung damage","author":"Cox","year":"2020","journal-title":"Sci. News"},{"key":"10.1016\/j.lfs.2020.117839_bb0540","series-title":"The Scientist Exploring Life, Inspiring Innovation","article-title":"Lost smell and taste hint COVID-19 can target the nervous system","author":"Yeager","year":"2020"},{"key":"10.1016\/j.lfs.2020.117839_bb0545","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","article-title":"Molecular immune pathogenesis and diagnosis of COVID-19","volume":"10","author":"Li","year":"2020","journal-title":"Journal of Pharmaceutical Analysis"},{"key":"10.1016\/j.lfs.2020.117839_bb0550","first-page":"1","article-title":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic","volume":"38","author":"Prompetchara","year":"2020","journal-title":"Asian Pac. J. Allergy Immunol."},{"key":"10.1016\/j.lfs.2020.117839_bb0555","first-page":"1","article-title":"Signals of Th2 immune response from COVID-19 patients requiring intensive care","author":"Roncati","year":"2020","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.lfs.2020.117839_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154895","article-title":"MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines\/chemokines and elevated inflammatory innate immune response in the lower respiratory tract","volume":"126","author":"Alosaimi","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.lfs.2020.117839_bb0565","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","article-title":"T cell responses to whole SARS coronavirus in humans","volume":"181","author":"Li","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2020.117839_bb0570","series-title":"B Cells Over-Activation by Viral Proteins <70 kDa Causes Th2 Immune Suppression in COVID-19 Sepsis","author":"Mart\u00edn","year":"2020"},{"key":"10.1016\/j.lfs.2020.117839_bb0575","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ctm2.16","article-title":"Acute lung injury in patients with COVID-19 infection","volume":"10","author":"Li","year":"2020","journal-title":"Clinical and Translational Medicine"},{"key":"10.1016\/j.lfs.2020.117839_bb0580","first-page":"E1269","article-title":"The ocular surface and the coronavirus disease 2019: does a dual \u2018ocular route\u2019exist?","volume":"9","author":"Napoli","year":"2020","journal-title":"Multidisciplinary Digital Publishing Institute"},{"key":"10.1016\/j.lfs.2020.117839_bb0585","first-page":"783","article-title":"Mechanism of the action between the SARS-CoV S240 protein and the ACE2 receptor in eyes","volume":"6","author":"Sun","year":"2006","journal-title":"Int J Ophthalmol-Chi"},{"key":"10.1016\/j.lfs.2020.117839_bb0590","article-title":"Atlas of ACE2 gene expression in mammals reveals novel insights in transmission of SARS-Cov-2","author":"Sun","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.lfs.2020.117839_bb0595","first-page":"E1","article-title":"Humans, viruses, and the eye\u2014An early report from the COVID-19 front line","author":"Sommer","year":"2020","journal-title":"JAMA Ophthalmology"},{"key":"10.1016\/j.lfs.2020.117839_bb0600","first-page":"1","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","author":"Sungnak","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0605","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jmv.25725","article-title":"Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection","volume":"92","author":"Xia","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.lfs.2020.117839_bb0610","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.lfs.2020.117839_bb0615","article-title":"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China","author":"Zhang","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lfs.2020.117839_bb0620","series-title":"Active or Latent Tuberculosis Increases Susceptibility to COVID-19 and Disease Severity, medRxiv","author":"Liu","year":"2020"},{"key":"10.1016\/j.lfs.2020.117839_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijtb.2020.05.006","article-title":"COVID-19 and tuberculosis: a mathematical model based forecasting in Delhi, India","author":"Marimuthu","year":"2020","journal-title":"Indian J. Tuberc."},{"key":"10.1016\/j.lfs.2020.117839_bb0635","doi-asserted-by":"crossref","first-page":"E362","DOI":"10.1016\/S2352-3026(20)30109-5","article-title":"Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19","volume":"7","author":"Tao Wang","year":"2020","journal-title":"Lancet Hematology"},{"key":"10.1016\/j.lfs.2020.117839_bb0640","unstructured":"E.F.d.B. Andy Haines, Anita Berlin, M.J.H. David L Heymann, Centring sexual and reproductive health and justice in the global COVID-19 response, Lancet, (2020)."},{"key":"10.1016\/j.lfs.2020.117839_bb0645","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2215-0366(20)30090-0","article-title":"Patients with mental health disorders in the COVID-19 epidemic","volume":"7","author":"Yao","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.lfs.2020.117839_bb0650","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1329","article-title":"The dilemma of coronavirus disease 2019, aging, and cardiovascular disease: insights from cardiovascular aging science","author":"AlGhatrif","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.lfs.2020.117839_bb0655","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00001432-200112000-00015","article-title":"The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase","volume":"14","author":"Cameron","year":"2001","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117839_bb0660","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/JVI.79.3.1943-1947.2005","article-title":"The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase","volume":"79","author":"Leyssen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2020.117839_bb0665","first-page":"62","article-title":"Therapeutic opportunities to manage COVID-19\/SARS-CoV-2 infection: present and future","volume":"61","author":"Shetty","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.lfs.2020.117839_bb0670","series-title":"Prog. Drug Res","first-page":"41","article-title":"Pleiotropic mechanisms of ribavirin antiviral activities","author":"Hong","year":"2002"},{"key":"10.1016\/j.lfs.2020.117839_bb0675","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2020.117839_bb0680","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-139-9-200311040-00005","article-title":"Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong","volume":"139","author":"Choi","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0685","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/thx.2003.014076","article-title":"Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak","volume":"59","author":"Sung","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2020.117839_bb0690","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/thorax.58.8.686","article-title":"Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)","volume":"58","author":"Chan","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.lfs.2020.117839_bb0695","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/378304","article-title":"Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada","volume":"37","author":"Knowles","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117839_bb0700","series-title":"Antiviral Agents and Corticosteroids in the Treatment of Severe Acute Respiratory Syndrome (SARS)","author":"Yu","year":"2004"},{"key":"10.1016\/j.lfs.2020.117839_bb0705","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1056\/NEJM200305153482017","article-title":"The use of corticosteroids in SARS","volume":"348","author":"Oba","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0710","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(02)11772-7","article-title":"Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?","volume":"360","author":"Cheung","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117839_bb0715","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/jac\/dki346","article-title":"Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital","volume":"56","author":"Yeh","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.lfs.2020.117839_bb0720","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1469-0691.2004.00956.x","article-title":"Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients","volume":"10","author":"Soo","year":"2004","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.lfs.2020.117839_bb0725","first-page":"309","article-title":"Treatment of severe acute respiratory syndrome with convalescent plasma","volume":"9","author":"Burnouf","year":"2003","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.lfs.2020.117839_bb0730","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2005","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.lfs.2020.117839_bb0735","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.lfs.2020.117839_bb0740","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0140-6736(20)30858-8","article-title":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed","volume":"395","author":"Feldmann","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117839_bb0745","series-title":"Tumor Necrosis Factor (TNF) Inhibitors, StatPearls [Internet]","author":"Gerriets","year":"2019"},{"key":"10.1016\/j.lfs.2020.117839_bb0750","first-page":"639","article-title":"Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up","volume":"80","author":"Wang","year":"2020","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.lfs.2020.117839_bb0755","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/nm.3985","article-title":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence","volume":"21","author":"Menachery","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2020.117839_bb0760","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1161\/HYPERTENSIONAHA.109.138420","article-title":"Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II\u2013dependent hypertension","volume":"55","author":"Wysocki","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.lfs.2020.117839_bb0765","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.kint.2020.04.009","article-title":"Blockade of SARS-CoV-2 infection by recombinant soluble ACE2","volume":"97","author":"Alhenc-Gelas","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2020.117839_bb0770","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1042\/CS20200163","article-title":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?","volume":"134","author":"Batlle","year":"2020","journal-title":"Clin. Sci."},{"key":"10.1016\/j.lfs.2020.117839_bb0775","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.cell.2007.02.048","article-title":"An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling","volume":"129","author":"Fukao","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.117839_bb0780","doi-asserted-by":"crossref","first-page":"P1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"95","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.117839_bb0785","series-title":"Coronavirus Disease (COVID-19) Pandemic","author":"WHO Report","year":"2020"},{"key":"10.1016\/j.lfs.2020.117839_bb0790","series-title":"COVID-19: Immunopathology and its Implications for Therapy","author":"Cao","year":"2020"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520305890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520305890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:34:17Z","timestamp":1758400457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520305890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":156,"alternative-id":["S0024320520305890"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117839","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronaviruses pathogenesis, comorbidities and multi-organ damage \u2013 A review","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117839","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117839"}}